James Fidelholtz, MD
Geriatric Medicine · Cincinnati, OHNPI 1245449438
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 383 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 383 payments — averaging $40.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Novo Nordisk$2K
- AbbVie$2K
- Johnson & Johnson$951
- Pfizer$934
- GSK$877
- plus $6K from 33 others
Across 105 payments — averaging $3953.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ironwood Pharmaceuticals, Inc$181K
- Pfizer$110K
- Regeneron$65K
- Acadia Pharmaceuticals Inc$41K
- Swedish Orphan Biovitrum AB$19K
What the payments were for
- Consulting fees$3622%
- Food & beverage$15,04097%
- Education$610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 62 | $2,810 |
| Novo Nordisk | 60 | $2,081 |
| AbbVie(2 entities) | 30 | $1,617 |
| Johnson & Johnson | 29 | $951 |
| Pfizer | 29 | $934 |
| GSK | 24 | $877 |
| Lilly USA, LLC | 29 | $724 |
| Otsuka America Pharmaceutical, Inc. | 6 | $522 |
| Xeris Pharmaceuticals, Inc. | 10 | $464 |
| Amgen | 6 | $420 |
| BD | 1 | $362 |
| Sunovion Pharmaceuticals Inc. | 4 | $361 |
| Boehringer Ingelheim | 4 | $321 |
| Bayer | 8 | $290 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $271 |
| Amarin Pharma, Inc. | 10 | $263 |
| Exact Sciences | 5 | $257 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $237 |
| Vanda Pharmaceuticals Inc. | 2 | $228 |
| Merck | 12 | $182 |
| Esperion Therapeutics, Inc. | 4 | $175 |
| Boston Scientific | 2 | $160 |
| Abbott | 8 | $152 |
| Phathom Pharmaceuticals, Inc. | 1 | $126 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Aimmune Therapeutics, Inc. | 1 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
| Astellas Pharma US Inc | 4 | $57 |
| Eisai Inc. | 3 | $50 |
| Urovant Sciences Inc | 1 | $49 |
| Scilex Pharmaceuticals Inc. | 1 | $40 |
| CMP Pharma, Inc. | 2 | $34 |
| Dexcom, Inc. | 2 | $32 |
| Grifols USA, LLC | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Covis Pharma GmbH | 1 | $17 |
| Bausch Health US, LLC | 1 | $12 |
| Neurelis, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,463 in reported general payments places this provider in the 95th percentile of 146 geriatric medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 50 | $60,563 |
| EliquisApixaban | 70 | $52,768 |
| OzempicSemaglutide | 32 | $51,139 |
| MounjaroTirzepatide | 15 | $26,302 |
| FarxigaDapagliflozin Propanediol | 16 | $24,157 |
| JanuviaSitagliptin Phosphate | 18 | $23,234 |
| MyrbetriqMirabegron | 22 | $12,108 |
| TradjentaLinagliptin | 12 | $6,188 |
| Lidocaine | 33 | $6,102 |
| Atorvastatin Calcium | 655 | $5,837 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 122 | $5,399 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 147 | $4,199 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $3,864 |
| Levothyroxine Sodium | 247 | $3,798 |
| Oxycodone Hcl | 116 | $3,576 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $321 | $66,75162 claims |
| PfizerEliquis | $934 | $52,76870 claims |
| Novo NordiskOzempic | $2,081 | $51,13932 claims |
| Lilly USA, LLCMounjaro, Humulin N | $724 | $27,25634 claims |
| AstraZenecaFarxiga | $2,810 | $24,15716 claims |
| MerckJanuvia | $182 | $23,23418 claims |
| Astellas Pharma US IncMyrbetriq | $57 | $12,10822 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $40 | $2,11814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 146 geriatric medicine providers in Ohio.
Other geriatric medicine in Cincinnati
- Milla KarevCincinnati$5K
- Amanda JudeCincinnati$4K
- Emmanuel RiveraCincinnati$2K
- Robert KeyesCincinnati$965
- Syed MoqeethCincinnati$676
- Shachi SinghCincinnati$426
- Jeffrey LeksonCincinnati$373
- Amanda ArnoldCincinnati$310
- Meenakshi PatelCenterville$644K
- Daniel CannoneWadsworth$423K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.